LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular Experience.

    Mishra, Kavita K / Afshar, Armin / Thariat, Juliette / Shih, Helen A / Scholey, Jessica E / Daftari, Inder K / Kacperek, Andrzej / Pica, Alessia / Hrbacek, Jan / Dendale, Remi / Mazal, Alejandro / Heufelder, Jens / Char, Devron H / Sauerwein, Wolfgang A G / Weber, Damien C / Damato, Bertil E

    Advances in radiation oncology

    2020  Volume 5, Issue 4, Page(s) 682–686

    Abstract: ... Co-Operative Group is the largest international community of particle/proton therapy providers. Participating ... COVID-19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy ... Co-Operative Group Ocular subcommittee with long-standing high-volume proton ocular programs. The practices ...

    Abstract Uveal melanoma (UM) is a rare but life-threatening cancer of the eye. In light of the coronavirus disease (COVID-19) pandemic, hospitals and proton eye therapy facilities must analyze several factors to ensure appropriate treatment protocols for patients and provider teams. Practice considerations to limit COVID-19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy Co-Operative Group is the largest international community of particle/proton therapy providers. Participating experts have current or former affiliation with the member institutions of the Particle Therapy Co-Operative Group Ocular subcommittee with long-standing high-volume proton ocular programs. The practices reviewed in this document must be taken in conjunction with local hospital procedures, multidisciplinary recommendations, and regional/national guidelines, as each community may have its unique needs, supplies, and protocols. Importantly, as the pandemic evolves, so will the strategies and recommendations. Given the unique circumstances for UM patients, along with indications of potential ophthalmologic transmission as a result of health care providers working in close proximity to patients and intrinsic infectious risk from eyelashes, tears, and hair, practice strategies may be adapted to reduce the risk of viral transmission. Certainly, providers and health care systems will continue to examine and provide as safe and effective care as possible for patients in the current environment.
    Keywords covid19
    Language English
    Publishing date 2020-04-23
    Publishing country United States
    Document type Journal Article
    ISSN 2452-1094
    ISSN 2452-1094
    DOI 10.1016/j.adro.2020.04.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic Particle Therapy Co Operative Group Ocular Experience

    Mishra, K.K. / Afshar, A. / Thariat, J. / Shih, H.A. / Scholey, J.E. / Daftari, I.K. / Kacperek, A. / Pica, A. / Hrbacek, J. / Dendale, R. / Mazal, A. / Heufelder, J. / Char, D.H. / Sauerwein, W.A.G. / Weber, D.C. / Damato, B.E.

    2020  

    Abstract: ... Co Operative Group is the largest international community of particle proton therapy providers. Participating ... COVID 19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy ... Co Operative Group Ocular subcommittee with long standing high volume proton ocular programs. The practices ...

    Abstract Uveal melanoma UM is a rare but life threatening cancer of the eye. In light of the coronavirus disease COVID 19 pandemic, hospitals and proton eye therapy facilities must analyze several factors to ensure appropriate treatment protocols for patients and provider teams. Practice considerations to limit COVID 19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy Co Operative Group is the largest international community of particle proton therapy providers. Participating experts have current or former affiliation with the member institutions of the Particle Therapy Co Operative Group Ocular subcommittee with long standing high volume proton ocular programs. The practices reviewed in this document must be taken in conjunction with local hospital procedures, multidisciplinary recommendations, and regional national guidelines, as each community may have its unique needs, supplies, and protocols. Importantly, as the pandemic evolves, so will the strategies and recommendations. Given the unique circumstances for UM patients, along with indications of potential ophthalmologic transmission as a result of health care providers working in close proximity to patients and intrinsic infectious risk from eyelashes, tears, and hair, practice strategies may be adapted to reduce the risk of viral transmission. Certainly, providers and health care systems will continue to examine and provide as safe and effective care as possible for patients in the current environment
    Keywords Inhouse research on structure dynamics and function of matter
    Subject code 610
    Language Undetermined
    Publishing date 2020-01-01
    Publishing country de
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top